Immunohistochemical diagnostic procedures reveal that 60% of patients have slight expression of CD34 (vascular origin), 21% have spinal muscular atrophy (epithelial and/or glandular origin), and 8% reveal desmin (muscular origin) [3]. The gene discussed is CD34; the disease is spinal muscular atrophy.